ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,925, issued on Nov. 11, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.) and PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Mass.).

"CRISPR effector system based diagnostics for hemorrhagic fever detection" was invented by Pardis Sabeti (Cambridge, Mass.), Cameron Myhrvold (Cambridge, Mass.), Catherine Amanda Freije (Cambridge, Mass.), Anna Elizabeth Lachenauer (Cambridge, Mass.) and Kayla Grace Barnes (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The embodiments disclosed herein utilize RNA targeting effectors to provide a robust CRISPR-based diagnostic for hemorrhagic fever virus applications. Embodiments disclo...